More recently, Cx-inhibiting peptides (antiarrhythmic peptides AAP10; ZP123; GAP-134; RXP-E; and the Cx43 mimetic peptides Gap 26 and Gap 27) were suggested for the treatment of arrhythmias in patients with ischemic cardiomyopathy [60]. The gene discussed is GJA1; the disease is Arrhythmia.